InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Fouse Jacqualyn A, 董事长兼首席执行官. Insider active across 5 companies, notably INCYTE CORP. Cumulatively, 31 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €176k. Activity tracked since 26 May 2021. The latest transaction was disclosed on 20 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Fouse Jacqualyn A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报31 总计
2,816 股Common stockSEC:0001439222-26-000101:0
454 股Common StockSEC:0001628280-26-044325:0
1,642 股Common StockSEC:0001405288-26-000006:0
203 股0Common StockSEC:0001628280-25-032855:0
2,120 股0Common stockSEC:0001439222-25-000055:0
2,518 股0Common StockSEC:0001628280-25-031013:0
15,933 股0Common stockSEC:0001439222-25-000029:0
894 股0Common StockSEC:0001628280-25-012364:0
3,388 股0Common stockSEC:0001439222-24-000089:0
2,830 股0Common StockSEC:0000879169-24-000096:0
15,934 股0Common stockSEC:0001439222-24-000063:0
23,900 股0Common stockSEC:0001439222-24-000016:0
17,500 股0Common stockSEC:0001439222-24-000008:0
8,391 股@ US$22.99100.0% 占其流量Common stockSEC:0001439222-24-000008:1
23,900 股0Common stockSEC:0001439222-23-000107:0
2,505 股0Common StockSEC:0001209191-23-037797:0
15,933 股0Common stockSEC:0001439222-23-000059:0
11,333 股0Common stockSEC:0001439222-23-000024:0
252 股@ US$80.3210.4% 占其流量Common StockSEC:0001209191-23-000801:0
291 股@ US$66.6410.8% 占其流量Common StockSEC:0001209191-22-052164:0
275 股@ US$75.970.0001% mcap13.9% 占其流量Common StockSEC:0001209191-22-040182:0
2,144 股0Common StockSEC:0001209191-22-037800:0
280 股@ US$79.420.0001% mcap14.0% 占其流量Common StockSEC:0001209191-22-022293:0
12,379 股0Common stockSEC:0001439222-22-000017:0
11,334 股0Common stockSEC:0001439222-22-000012:0
31 条申报中的 25 条
About Fouse Jacqualyn A
FOUSE JACQUALYN A is Président-Directeur Général. She has 31 filings in total. Across the 31 sampled recent filings, the recorded amounts show EUR 0 of buys and EUR 176145 of sells, with a date range from 2016-02-16 to 2026-06-23. The filings concern INCYTE CORP, AGIOS PHARMACEUTICALS, INC., Agios Pharmaceuticals, INC., Madrigal Pharmaceuticals, INC. and CELGENE CORP /DE/, and the modal transaction nature is Attribution.
